• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨微阵列和甲基化测序技术的变异性分析及表观遗传年龄预测

Analysis of variability and epigenetic age prediction across microarray and methylation sequencing technologies.

作者信息

Shokhirev Maxim N, Johnson Adiv A

机构信息

Tally Health, New York, NY, USA.

出版信息

Geroscience. 2025 Aug 11. doi: 10.1007/s11357-025-01824-1.

DOI:10.1007/s11357-025-01824-1
PMID:40784975
Abstract

Using 100 technical replicate samples from two adult buccal cohorts, we compared technical methylation variability and signal strength between the Infinium MethylationEPIC v2.0 array and the Twist Human Methylome Panel across 753,648 shared CpGs. Twist methylation sequencing showed skewed methylation distributions and fewer highly correlated CpGs than MethylationEPIC arrays. Variance analysis revealed a skew toward higher signal strength in MethylationEPIC datasets, with a subset of CpGs showing high signal strength in both methylation sequencing and array datasets. Despite these biases, four principal component (PC) trained epigenetic clocks (pcHorvath1, pcHorvath2, pcHannum, and pcDNAm PhenoAge) were robust across both technologies, even with missing data. While pcHannum and pcDNAm PhenoAge were similarly reproducible with mean absolute replicate difference (MRD) values ranging from 1.014 years to 1.194 years, pcHorvath1 was more reproducible in arrays (MRD = 0.459 years) than methylation sequencing (MRD = 2.320 years) and pcHorvath2 was more reproducible in methylation sequencing (MRD = 0.760 years) than arrays (MRD = 1.011 years). Furthermore, original non-PC versions of these clocks were less reproducible in Twist datasets and, as an example of this, MRD for uncorrected clocks went as high as 15.498 years in arrays and as high as 20.180 years in methylation sequencing. Obvious differences in age prediction were also observed in original clocks compared to their PC-trained versions across both technologies (with a mean absolute difference ranging from 4.492 years to 46.724 years). This underscores the need for careful selection of epigenetic clocks and technology-specific adjustments when optimizing for accuracy and reproducibility.

摘要

我们使用来自两个成人颊部队列的100个技术重复样本,比较了Infinium MethylationEPIC v2.0阵列和Twist人类甲基化组面板在753,648个共享CpG位点上的技术甲基化变异性和信号强度。Twist甲基化测序显示甲基化分布存在偏差,且与MethylationEPIC阵列相比,高度相关的CpG位点更少。方差分析显示MethylationEPIC数据集的信号强度倾向于更高,有一部分CpG位点在甲基化测序和阵列数据集中均显示出高信号强度。尽管存在这些偏差,但四个主成分(PC)训练的表观遗传时钟(pcHorvath1、pcHorvath2、pcHannum和pcDNAm PhenoAge)在两种技术中都很稳健,即使存在缺失数据。虽然pcHannum和pcDNAm PhenoAge的平均绝对重复差异(MRD)值在1.014年至1.194年之间,具有相似的可重复性,但pcHorvath1在阵列中的可重复性更高(MRD = 0.459年),而在甲基化测序中的可重复性较低(MRD = 2.320年),pcHorvath2在甲基化测序中的可重复性更高(MRD = 0.760年),而在阵列中的可重复性较低(MRD = 1.011年)。此外,这些时钟的原始非PC版本在Twist数据集中的可重复性较低,例如,未校正时钟在阵列中的MRD高达15.498年,在甲基化测序中的MRD高达20.180年。与两种技术中它们的PC训练版本相比,原始时钟在年龄预测方面也存在明显差异(平均绝对差异范围为4.492年至46.724年)。这强调了在优化准确性和可重复性时,需要仔细选择表观遗传时钟并进行特定技术调整。

相似文献

1
Analysis of variability and epigenetic age prediction across microarray and methylation sequencing technologies.跨微阵列和甲基化测序技术的变异性分析及表观遗传年龄预测
Geroscience. 2025 Aug 11. doi: 10.1007/s11357-025-01824-1.
2
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
3
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Improved epigenetic age prediction models by combining sex chromosome and autosomal markers.通过结合性染色体和常染色体标记改进表观遗传年龄预测模型。
Epigenetics Chromatin. 2025 Jul 15;18(1):45. doi: 10.1186/s13072-025-00606-5.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
First-generation versus next-generation epigenetic aging clocks: Differences in performance and utility.第一代与新一代表观遗传衰老时钟:性能与效用的差异
Biogerontology. 2025 Jun 18;26(4):121. doi: 10.1007/s10522-025-10265-4.

本文引用的文献

1
First-generation versus next-generation epigenetic aging clocks: Differences in performance and utility.第一代与新一代表观遗传衰老时钟:性能与效用的差异
Biogerontology. 2025 Jun 18;26(4):121. doi: 10.1007/s10522-025-10265-4.
2
DNAm age differences between infinium methylationEPICv1 vs EPICv2 in buffy coat, PBMC, and saliva samples.血沉棕黄层、外周血单个核细胞及唾液样本中Infinium甲基化EPIC v1与EPIC v2之间的DNA甲基化年龄差异。
Commun Biol. 2025 Apr 23;8(1):654. doi: 10.1038/s42003-025-08021-y.
3
Applicability of epigenetic age models to next-generation methylation arrays.
表观遗传年龄模型在下一代甲基化阵列中的适用性。
Genome Med. 2024 Oct 7;16(1):116. doi: 10.1186/s13073-024-01387-4.
4
CheekAge: a next-generation buccal epigenetic aging clock associated with lifestyle and health.颊部年龄:一种与生活方式和健康相关的新一代颊部表观遗传衰老时钟。
Geroscience. 2024 Jun;46(3):3429-3443. doi: 10.1007/s11357-024-01094-3. Epub 2024 Mar 5.
5
A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking.一种增强表观遗传时钟可靠性的计算解决方案:对临床试验和纵向跟踪的影响。
Nat Aging. 2022 Jul;2(7):644-661. doi: 10.1038/s43587-022-00248-2. Epub 2022 Jul 15.
6
Evaluation of short-term epigenetic age fluctuation.评估短期表观遗传年龄波动。
Clin Epigenetics. 2022 Jun 9;14(1):76. doi: 10.1186/s13148-022-01293-9.
7
Biohorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities.生物年代学与衰老生物标志物:当前的最新进展、挑战与机遇。
Ageing Res Rev. 2020 Jul;60:101050. doi: 10.1016/j.arr.2020.101050. Epub 2020 Apr 6.
8
DNA methylation GrimAge strongly predicts lifespan and healthspan.DNA甲基化GrimAge能有力地预测寿命和健康跨度。
Aging (Albany NY). 2019 Jan 21;11(2):303-327. doi: 10.18632/aging.101684.
9
Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and studies.应用于哈钦森-吉尔福德早衰综合征及相关研究的皮肤和血细胞表观遗传时钟。
Aging (Albany NY). 2018 Jul 26;10(7):1758-1775. doi: 10.18632/aging.101508.
10
An epigenetic biomarker of aging for lifespan and healthspan.一种用于寿命和健康寿命的衰老表观遗传生物标志物。
Aging (Albany NY). 2018 Apr 18;10(4):573-591. doi: 10.18632/aging.101414.